HOXA7

HOXA7 Full Name

homeobox A7

HOXA7 Introduction

Homeobox A7 (HOXA7) is a key transcription factor belonging to the HOX gene family, which plays a fundamental role in embryonic development, tissue patterning, and cellular differentiation. As a member of the Homeobox A cluster located on human chromosome 7p15.2, HOXA7 contains a highly conserved 60-amino-acid homeodomain that mediates specific binding to DNA, thereby regulating the expression of target genes involved in cell proliferation, apoptosis, migration, and lineage commitment. This gene is dynamically expressed during embryonic development, with prominent expression in the developing central nervous system, axial skeleton, limbs, and respiratory tract, where it contributes to the spatial patterning and morphogenesis of these structures. Today, HOXA7 is recognized not only as a critical regulator of embryonic development but also as a key player in adult tissue homeostasis and disease progression, with profound implications for developmental biology, oncology, and regenerative medicine.

Figure 1.Structure of HOXA7.

Expression Pattern and Regulatory Mechanisms of HOXA7
HOXA7 exhibits a tightly regulated, spatiotemporal expression pattern during embryonic development and is dynamically modulated in adult tissues. In the developing embryo, HOXA7 expression is initially detected in the posterior neural tube and paraxial mesoderm, gradually expanding to the developing limbs, thoracic and abdominal regions, and respiratory epithelium. Its expression is tightly controlled by epigenetic modifications (including DNA methylation and histone acetylation) and upstream regulatory factors, such as retinoic acid signaling, which plays a pivotal role in activating HOX gene expression during embryonic patterning. In adult tissues, HOXA7 is expressed at low levels in most normal tissues but is aberrantly upregulated or downregulated in various pathological conditions, particularly cancer. The regulatory network of HOXA7 involves interactions with other HOX family members (forming heterodimers or homodimers) and non-HOX transcription factors, allowing it to fine-tune the expression of downstream target genes involved in cell fate determination and tissue homeostasis.

Clinical Significance of HOXA7 Dysregulation
Dysregulation of HOXA7 expression is closely associated with a variety of human diseases, most notably cancer, as well as developmental disorders. Aberrant overexpression of HOXA7 has been observed in multiple types of cancer, including breast cancer, lung cancer, ovarian cancer, and leukemia, where it acts as an oncogene to promote tumor cell proliferation, invasion, and metastasis by activating downstream oncogenic signaling pathways and inhibiting apoptotic pathways. Conversely, reduced HOXA7 expression has been linked to developmental abnormalities, such as congenital malformations of the skeleton, central nervous system, and respiratory tract, resulting from impaired embryonic patterning. The estimated frequency of HOXA7 dysregulation varies across cancer types, with high expression detected in approximately 30–50% of breast and lung cancer cases. Furthermore, HOXA7 expression levels have been proposed as a potential prognostic biomarker and therapeutic target for cancer, as targeting its expression or activity may inhibit tumor progression and improve patient outcomes.

Alternate Names for HOXA7

HOXA7; homeobox A7; homeo box A7; HOX1, HOX1A; homeobox protein Hox-A7; homeo box A7; homeobox protein HOX-1A; homeobox protein Hox 1.1; ANTP; HOX1; HOX1A; HOX1.1;